Quantitative imaging and dynamics of tumor therapy with viruses
Related Experiment Video
Updated: Oct 30, 2025
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
Published on: June 21, 2011
Iris Kemler1, Bhargav Karamched2, Claudia Neuhauser3
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Abstract:
Cancer therapy remains challenging due to the myriad presentations of the disease and the vast genetic diversity of tumors that continuously evolve and often become resistant to therapy. Viruses can be engineered to specifically infect, replicate, and kill tumor cells (tumor virotherapy). Moreover, the viruses can be "armed" with therapeutic genes to enhance their oncolytic effect. Using viruses to treat cancer is exciting and novel and in principle can be used for a broad variety of tumors. However, the approach is distinctly different from other cancer therapies since success depends on establishment of an infection within the tumor and ongoing propagation of the oncolytic virus within the tumor itself. Therefore, the target itself amplifies the therapy. This introduces complex dynamics especially when the immune system is taken into consideration as well as the physical and other biological barriers to virus growth. Understanding these dynamics not only requires mathematical and computational models but also approaches for the noninvasive monitoring of the virus and tumor populations. In this perspective, we discuss strategies and current results to achieve this important goal of understanding these dynamics in pursuit of optimization of oncolytic virotherapy.
Insights
Oncolytic virotherapy uses engineered viruses to kill cancer cells, offering a novel therapeutic approach. Understanding complex tumor-virus-immune dynamics is crucial for optimizing this promising cancer treatment.
Area of Science:
- Oncology
- Virology
- Computational Biology
Background:
- Cancer therapy faces challenges due to tumor heterogeneity and evolving resistance.
- Oncolytic virotherapy engineers viruses to selectively infect and destroy tumor cells.
- Viruses can be genetically modified to enhance their tumor-killing capabilities.
Purpose of the Study:
- To explore strategies for understanding and optimizing oncolytic virotherapy.
- To address the complex dynamics of virus-tumor interactions and immune responses.
- To highlight the need for noninvasive monitoring of oncolytic viruses and tumors.
Main Methods:
- Discussion of mathematical and computational modeling approaches.
- Review of current strategies for monitoring virus and tumor populations.
- Analysis of biological and physical barriers affecting virus propagation.
Main Results:
- Oncolytic virotherapy presents a unique approach where the tumor amplifies the therapeutic agent.
- Success hinges on viral infection establishment and propagation within the tumor.
- Complex interactions involving the immune system and biological barriers influence treatment efficacy.
Conclusions:
- Optimizing oncolytic virotherapy requires a deep understanding of its complex dynamics.
- Noninvasive monitoring methods are essential for tracking virus and tumor populations.
- Further research into these dynamics will advance the clinical application of virotherapy.
